Could exercise hormone irisin be a therapeutic agent against Parkinson’s and other neurodegenerative diseases?

Parkinson’s disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease (AD). The pathologic hallmarks of the disease are the loss of dopaminergic neurons of substantia nigra pars compacta and the presence of intraneuronal alpha synuclein (a-syn) aggregates. Clinical f...

Descripción completa

Detalles Bibliográficos
Autores principales: Avgerinos, Konstantinos I., Liu, Junli, Dalamaga, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918419/
https://www.ncbi.nlm.nih.gov/pubmed/36785617
http://dx.doi.org/10.1016/j.metop.2023.100233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918419/
https://www.ncbi.nlm.nih.gov/pubmed/36785617
http://dx.doi.org/10.1016/j.metop.2023.100233

Ejemplares similares